BridgeBio Pharma (BBIO) Interest Coverage Ratio Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 79.36% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 29.25% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -16.86% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.78% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 40.09% |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | -9.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.30% |
| Dec 31, 2025 | -22.88% |
| Sep 30, 2025 | -23.84% |
| Jun 30, 2025 | 3.37% |
| Mar 31, 2025 | 12.29% |
| Dec 31, 2024 | 1.36% |
| Sep 30, 2024 | 14.94% |
| Jun 30, 2024 | 4.09% |
| Mar 31, 2024 | 26.01% |
| Dec 31, 2023 | 9.04% |
| Sep 30, 2023 | 10.89% |
| Jun 30, 2023 | 15.08% |
| Mar 31, 2023 | 37.40% |
| Dec 31, 2022 | 37.01% |
| Sep 30, 2022 | 36.81% |
| Jun 30, 2022 | 51.98% |
| Mar 31, 2022 | 39.29% |
| Dec 31, 2021 | 41.84% |
| Sep 30, 2021 | 27.78% |
| Jun 30, 2021 | 62.89% |